1 unknown, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Unknown 1 |
Follow tolfenamic acid: new trials by email Literature Review of tolfenamic acid trials Research Report on tolfenamic acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks Tolfenamic Acid, Placebos - Progressive Supranuclear Palsy | Phase 1 / Phase 2 | Unknown | NeuroTau, Inc. | 24 | 2021-01-01 | 2020-02-05 |
| Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation Tolfenamic acid + gemcitabine + radiation - Pancreatic Cancer | Phase 1 | Withdrawn | Orlando Health, Inc. | 2014-03-01 | 2015-04-28 |
Pancreatic Neoplasms (1) · Supranuclear Palsy, Progressive (1)
NeuroTau, Inc. (1) · Orlando Health, Inc. (1)
United States (2)
Marwan Sabbagh, MD (1) · Nasser Zawia, PhD (1) · Omar R Kayaleh, M.D. (1)